Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
GPR15 Biologics Sequence Review Report 2026: G protein-coupled receptor 15 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR12 Biologics Sequence Review Report 2026: G protein-coupled receptor 12 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR12 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR6 Biologics Sequence Review Report 2026: G protein-coupled receptor 6 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR4 Biologics Sequence Review Report 2026: G protein-coupled receptor 4 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR3 Biologics Sequence Review Report 2026: G protein-coupled receptor 3 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR183 Biologics Sequence Review Report 2026: G protein-coupled receptor 183 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR183 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF8 Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 8 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PTPRM Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase mu Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PTPRM protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
KLRK1 Biologics Sequence Review Report 2026: NKG2-D type II integral membrane protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KLRK1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
KLRC2 Biologics Sequence Review Report 2026: NKG2-C type II integral membrane protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KLRC2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
KLRC1 Biologics Sequence Review Report 2026: NKG2-A/NKG2-B type II integral membrane protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KLRC1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PTPRG Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase gamma Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PTPRG protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
591
592
593
594
595
>>
1905
>